Neuroimaging Correlates of Post-COVID-19 Symptoms: A Functional MRI Approach.

Neuroimaging Correlates of Post-COVID-19 Symptoms: A Functional MRI Approach.

Publication date: Sep 29, 2024

Post-COVID syndrome is characterized by persistent symptoms, including fatigue and cognitive impairment. These symptoms may be experienced by up to 80% of patients. We aimed to identify possible patterns of brain activation underlying post-COVID fatigue. The study used functional MRI (Siemens MAGNETOM Prisma 3T scanner with a specially created protocol) of the brain in 30 patients with post-COVID fatigue syndrome and 20 healthy volunteers. Task functional MRI (fMRI) was performed using a cognitive paradigm (modified Stroop test). Eligible patients included adults aged 18-50 years with a >12 weeks before enrolment (less than 12 months) prior history of documented COVID-19 with symptoms of fatigue not attributable to any other cause, and with MFI-20 score > 30 and MoCA at first visit. Healthy control participants had no prior history of COVID-19 and negative tests for severe acute coronavirus respiratory syndrome with MFI-20 score < 30 and MoCA at first visit. Task fMRI data were processed using the SPM12 software package based on MATLAB R2022a. Cognitive task fMRI analysis showed significantly higher activation in the post-COVID group versus healthy volunteers' group. Between-group analysis showed significant activation differences. Using a threshold of T > 3 we identified eight clusters of statistically significant activation: supramarginal gyri, posterior cingulate cortex, opercular parts of precentral gyri and cerebellum posterior lobe bilaterally. Post-COVID fatigue syndrome associated with subjective cognitive impairment could show changes in brain functional activity in the areas connected with information processing speed and quality.

Open Access PDF

Concepts Keywords
Adults cognitive impairment
Coronavirus COVID-19
Mri fMRI
Spm12 post-COVID fatigue
Volunteers

Semantics

Type Source Name
disease MESH COVID-19
disease MESH syndrome
disease MESH cognitive impairment
disease IDO history
disease IDO quality
disease MESH Long Covid
drug DRUGBANK Diflunisal
disease IDO entity
disease MESH anosmia
disease MESH ageusia
disease MESH sequelae
drug DRUGBANK Coenzyme M
disease IDO blood
drug DRUGBANK Oxygen
disease IDO process
disease MESH coronavirus infection
drug DRUGBANK Flunarizine
disease MESH stroke
disease MESH neoplasms
disease MESH demyelination
disease IDO algorithm

Original Article

(Visited 1 times, 1 visits today)